Your browser doesn't support javascript.
loading
Prevalence of structural birth defects in IVF-ICSI pregnancies resulting from autologous and donor oocytes in Indian sub-continent: Results from 2444 births.
Banker, Manish; Arora, Parul; Banker, Jwal; Benani, Hetal; Shah, Sandeep; Lalitkumar, Parmeswaran Grace Luther.
Afiliação
  • Banker M; Nova-IVI Fertility, Ahmedabad, India.
  • Arora P; Nova-IVI Fertility, Ahmedabad, India.
  • Banker J; Srimati Bhikiben Kanjibhai Shah Medical Institute and Research Center, Vadodara, India.
  • Benani H; Nova-IVI Fertility, Ahmedabad, India.
  • Shah S; Nova-IVI Fertility, Ahmedabad, India.
  • Lalitkumar PGL; Nova-IVI Fertility, Bangalore, India.
Acta Obstet Gynecol Scand ; 98(6): 715-721, 2019 06.
Article em En | MEDLINE | ID: mdl-30663773
ABSTRACT

INTRODUCTION:

This study was conducted to evaluate and compare the incidence of birth defects in In-Vitro Fertilization-Intra Cytoplasmic Sperm Injection (IVF-ICSI) pregnancies with autologous and donor oocytes. As a secondary outcome, the prevalence of birth defects in IVF-ICSI pregnancies was compared with those from spontaneous conceptions in India. MATERIAL AND

METHODS:

This retrospective study included 2444 births resulting from IVF-ICSI cycles from autologous (n = 1743) and donor oocytes (n = 701) during a 3-year period in an Indian infertility center. Birth defects, if any, were noted antenatally and followed till the neonatal period, in case of live birth.

RESULTS:

The overall prevalence of birth defects in IVF-ICSI pregnancies in this study was 29/2444 (118.6/10 000 births) and the most common congenital anomaly was cardiac malformation (32.7/10 000 births) followed by genitourinary (28.6/10 000 births). The risks of birth defects resulting from autologous and donor oocytes did not differ (114.7/10 000 vs 128.38/10 000; P > 0.05). However, pregnancies resulting from autologous oocytes had a higher trend of gastrointestinal birth defects (20.5/10 000 births vs 0), though not statistically significant. The risk of cardiovascular birth defects resulting from IVF-ICSI pregnancies was much higher compared with the natural conceptions in India (32.7/10 000 vs 12.7/10 000 births; P = 0.03), whereas the risk of central nervous system malformations was much lower (8.1/10 000 vs 60.18/10 000 births; P = 0.005).

CONCLUSIONS:

Overall, there was no significant difference in birth defects resulting from IVF-ICSI with autologous or donor oocytes. The births resulting from IVF-ICSI pregnancies did not tend to have a higher rate of birth defects a compared with natural conceptions. The differences in the prevalence of certain birth defects (cardiovascular or central nervous system) reported in IVF-ICSI pregnancies may be due to improved surveillance modalities and early detection in pregnancies following IVF-ICSI. A study with larger number of sample size will give us better understanding of the prevalence of reported incidence in this study.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Congênitas / Resultado da Gravidez / Fertilização in vitro / Injeções de Esperma Intracitoplásmicas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Congênitas / Resultado da Gravidez / Fertilização in vitro / Injeções de Esperma Intracitoplásmicas Idioma: En Ano de publicação: 2019 Tipo de documento: Article